Holen Sie sich die Stockscreener-App
103.24
0.01%
0.010
Exact Sciences Corp Aktie (EXAS) Neueste Nachrichten
Exact Sciences misses Q4 expectations for earnings, beats for revenue - Wisconsin State Journal
Illinois Municipal Retirement Fund Boosts Stake in Exact Sciences Corporation $EXAS - MarketBeat
Decoding Exact Sciences Corp (EXAS): A Strategic SWOT Insight - GuruFocus
Exact Sciences (EXAS) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Finance
Exact Sciences: Q4 Earnings Snapshot - kens5.com
Exact Sciences (EXAS) Surpasses Q4 Revenue Expectations - GuruFocus
Exact Sciences Q4 Loss Narrows, Revenue Rises - marketscreener.com
EXACT SCIENCES CORP SEC 10-K Report - TradingView
Exact Sciences Corp. Reports Record Fourth Quarter and Full Year 2025 Results - TradingView
Exact Sciences Announces Record Fourth Quarter and Full Year 2025 Results - Business Wire
Is It Too Late To Consider Exact Sciences (EXAS) After The US$105 Abbott Offer - Yahoo Finance
Exact Sciences: Fourth Quarter Earnings Overview - Bitget
Mdxhealth to Present Fourth Quarter and Full Year 2025 Financial Results and Corporate Update on February 26 - GlobeNewswire Inc.
Alger Mid Cap 40 ETF Q4 2025 Portfolio Update - Seeking Alpha
Exact Sciences Corporation (NASDAQ:EXAS) Given Consensus Rating of "Hold" by Brokerages - MarketBeat
Take Profit: Will Exact Sciences Corporation benefit from green energy policiesLayoff News & Technical Buy Zone Confirmation - baoquankhu1.vn
Aug PreEarnings: Will Exact Sciences Corporation outperform its industry peersQuarterly Market Summary & Weekly Consistent Profit Watchlists - baoquankhu1.vn
Allianz Asset Management GmbH Makes New Investment in Exact Sciences Corporation $EXAS - MarketBeat
Biotech operator Personalis sees 10% spike from Medicare covering lung cancer blood test - Mugglehead Magazine
Exact Sciences (NASDAQ:EXAS) Sets New 12-Month HighTime to Buy? - MarketBeat
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Northfield Bancorp Inc. (NasdaqNFBK), Coterra Energy Inc. (NYSECTRA), Exact Sciences Corporation (Nasdaq – EXAS), Semrush Holdings, Inc. (NYSE – - ChartMill
Exact Sciences (EXAS): Buy, Sell, or Hold Post Q3 Earnings? - Finviz
Exact Sciences Milestone In Breast Cancer Genomics And What It Means For EXAS - Yahoo Finance
PTAB Tosses 2nd Patent On Cologuard Colon Cancer Test - Law360
Geneoscopy Wins Second Patent Trial and Appeal Board Decision, Invalidating All Challenged Claims of Exact Sciences’ ’746 Patent - The AI Journal
Exact Sciences (EXAS) Advances as HSR Period Expires for Abbott Deal - GuruFocus
The Truth About Exact Sciences Corp: Is This Cancer-Test Stock Quietly Going Viral or About to Flop? - AD HOC NEWS
Principal Financial Group Inc. Grows Position in Exact Sciences Corporation $EXAS - MarketBeat
C WorldWide Group Holding A S Has $46.97 Million Holdings in Exact Sciences Corporation $EXAS - MarketBeat
Exact Sciences Corporation $EXAS Shares Sold by Heritage Investors Management Corp - MarketBeat
Medicare coverage pathway established for multi-cancer detection tests By Investing.com - Investing.com Nigeria
Exact Sciences (EXAS) Applauds Medicare Coverage Pathway for Can - GuruFocus
Medicare coverage pathway established for multi-cancer detection tests - Investing.com
Exact Sciences welcomes Medicare coverage pathway for multi-cancer tests - StreetInsider
Exact Sciences Applauds Passage of Legislation Establishing Medicare Coverage Pathway for Multi-Cancer Early Detection Tests - Business Wire
Exact Sciences (NASDAQ:EXAS) Hits New 12-Month HighShould You Buy? - MarketBeat
Oncotype DX Breast Recurrence Score® Test Surpasses 2 Million Pa - GuruFocus
Exact Sciences stock hits 52-week high at $102.69 - Investing.com
Oncotype DX Breast Recurrence Score® Test Surpasses 2 Million Patients Worldwide - Business Wire
Multiple Tailwinds Lifted Exact Sciences Corporation (EXAS) in 2025 - Insider Monkey
Abbott (ABT) stock price steadies after Barclays trims target; Exact Sciences vote is next key date - TechStock²
Abbott’s Exact Sciences Deal Recasts Diagnostics While Nutrition Faces Reset - Yahoo Finance
Bear Alert: Is Exact Sciences Corporation showing insider buyingWeekly Stock Recap & Safe Entry Zone Identification - baoquankhu1.vn
Abbott Laboratories Resets Portfolio With Exact Sciences Cancer Diagnostics Deal - Yahoo Finance UK
Freedom Capital Markets upgrades Abbott Labs stock rating to Buy on Exact Sciences deal - Investing.com
Here Are Tuesday’s Top Wall Street Analyst Research Calls: Applied Materials, CDW, Exact Sciences, Harley-Davidson, Oshkosh, ServiceNow and More - AOL.com
Exact Sciences Corp. (EXAS) Rose Following the Acquisition Announcement - Insider Monkey
EFG Asset Management North America Corp. Purchases 12,900 Shares of Exact Sciences Corporation $EXAS - MarketBeat
Baillie Gifford & Co. Lowers Holdings in Exact Sciences Corporation $EXAS - MarketBeat
A Look At Exact Sciences (EXAS) Valuation After Its Strong Recent Share Price Momentum - Yahoo Finance
Is It Time To Reassess Exact Sciences (EXAS) After Its Strong One Year Share Price Run? - simplywall.st
Lobbying Update: $420,000 of EXACT SCIENCES lobbying was just disclosed - Quiver Quantitative
QRG Capital Management Inc. Has $641,000 Holdings in Exact Sciences Corporation $EXAS - MarketBeat
Halper Sadeh Investigates Potential Securities Violations by Penumbra, Exact Sciences, DigitalBridge, and Flushing Financial - Intellectia AI
Mizuho downgrades Exact Sciences (EXAS) - MSN
Short Squeeze: Is Village Farms International Inc stock a good pick for beginnersJuly 2025 Selloffs & AI Enhanced Trading Signals - baoquankhu1.vn
Assessing Exact Sciences: Insights From 16 Financial Analysts - Benzinga
Exact Sciences Corp.: How a Diagnostics Powerhouse Is Rewriting the Playbook on Early Cancer Detecti - AD HOC NEWS
0.00%
1.13%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):